A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The researchers are doing this study to find out whether the study drug, SDX-7320, when combined with the standard chemotherapy eribulin, is an effective treatment for people with TNBC and metabolic dysfunction. The researchers will also look at whether the study treatment (SDX-7320 combined with eribulin) is safe and causes few or mild side effects in participants. The researchers will compare this treatment approach to eribulin alone.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony potrójnie ujemny zaawansowany rak piersi (brak receptorów estrogenowych i progesteronowych, brak receptora HER2)
- •Zaawansowany lub przerzutowy nowotwór, który nie może być wyleczony operacyjnie, z maksymalnie 2 poprzednimi liniami leczenia
- •Wcześniejsze leczenie chemioterapią (antracykliny i taksany) lub pacjenci z nowo rozpoznanym przerzutowym rakiem piersi
- •Zaburzenia metaboliczne: podwyższony poziom cukru (HbA1c > 5,5) i/lub otyłość (BMI ≥ 30)
- •Mierzalne zmiany nowotworowe widoczne w badaniach lub przerzuty do kości
- •Ogólny stan zdrowia pozwalający na leczenie (ECOG ≤ 1)
- •Wiek co najmniej 18 lat i pisemna zgodę na udział w badaniu
- •Prawidłowe wyniki badań krwi: liczba białych krwinek, płytek krwi, hemoglobina, funkcja wątroby i nerek w normie
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- April 27, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (10)
BAPTIST ALLIANCE - MCI (Data Collection Only)
Miami, United States
Emory University (Data Collection Only)
Atlanta, United States
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, United States
Hackensack Meridian Health
Hackensack, United States
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, United States
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, United States
Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
Commack, United States
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, United States
Memorial Sloan Kettering Nassau (All Protocol Activities)
Uniondale, United States
Trial contact
Sherry Shen, MD
Tiffany Trainia, MD
Contact information from ClinicalTrials.gov. Contact in English.
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.